Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssensys Regulatory News (ESYS)

Share Price Information for Essensys (ESYS)

Share Price is delayed by 15 minutes
Get Live Data
16.75    0.00 (0.00%)
Bid:
16.00
Ask:
17.50
Spread: 1.50 (9.375%)
Market Cap: £11.07m
ESYS Live PriceLast checked at - London Stock Exchange

Intraday Essensys Share Chart

Form 8.5 (EPT/RI)

9 Feb 2026 10:48

RNS Number : 2582S
Canaccord Genuity Limited
09 February 2026
 

-

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Canaccord Genuity Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Essensys PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected to the Offeree

 

(d) Date dealing undertaken:

06 February 2026

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ord 0.25p

Purchases

2,932

16p

16p

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

Date of disclosure:

09 February 2026

Contact name:

David Baker

Telephone number:

020 7523 4656

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERDZGGZGLNGVZM
Date   Source Headline
23rd Oct 20237:00 amRNSInvestor Presentation via Investor Meet Company
19th Oct 20237:00 amRNSNotice of Results
6th Sep 20237:00 amRNSIssue of Equity and Total Voting Rights
31st Aug 20237:00 amRNSFull year trading update
4th Jul 20237:00 amRNSIssue of Equity and Total Voting Rights
28th Mar 20237:00 amRNSHalf year results
22nd Mar 202311:30 amRNSNotice of Results and Investor Presentation
28th Feb 20237:00 amRNSHalf Year Trading Update
6th Dec 20229:37 amRNSHolding(s) in Company
1st Dec 202212:04 pmRNSResult of AGM
1st Dec 20227:00 amRNSAGM Trading Update
7th Nov 20224:00 pmRNSPosting of 2022 Annual Report and Notice of AGM
1st Nov 20227:00 amRNSPublication of Audited Annual Report and Accounts
18th Oct 20227:00 amRNSFULL YEAR RESULTS
14th Oct 20227:00 amRNSNotice of Investor Presentation
26th Sep 20229:30 amRNSNotice of Results
16th Sep 202210:27 amRNSDirector/PDMR Shareholding
24th Aug 20227:00 amRNSFull Year Trading Update
17th May 20227:00 amRNSBoard Changes
9th May 20229:52 amRNSHolding(s) in Company
3rd May 20223:18 pmRNSDirector/PDMR Shareholding
26th Apr 20227:00 amRNSDirector/PDMR Shareholding
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
22nd Apr 202211:05 amRNSSecond Price Monitoring Extn
22nd Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 20229:05 amRNSSecond Price Monitoring Extn
21st Apr 20229:00 amRNSPrice Monitoring Extension
21st Apr 20227:00 amRNSHalf-year Report
29th Mar 20227:00 amRNSNotice of Investor Meet Company Presentation
22nd Mar 202210:46 amRNSHolding(s) in Company
18th Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20227:00 amRNSDirector/PDMR Shareholding
17th Mar 20225:56 pmRNSDirector/PDMR Shareholding
11th Mar 202210:08 amRNSNotice of Results
10th Mar 202212:31 pmRNSHolding(s) in Company
2nd Mar 20224:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
1st Mar 20227:00 amRNSTrading Update
7th Feb 20227:00 amRNSAppointment of CEO UK & Europe and PDMR Dealing
3rd Feb 20227:00 amRNSBoard Changes
2nd Dec 202111:20 amRNSResult of AGM
16th Nov 20212:46 pmRNSDirector/PDMR Shareholding
8th Nov 20215:54 pmRNSPosting of Annual Report and Accounts & AGM Notice
25th Oct 20215:04 pmRNSHolding(s) in Company
19th Oct 20217:00 amRNSFull Year Results
15th Oct 20217:00 amRNSNotice of Investor Meet Company Presentation
14th Oct 20217:00 amRNSCustomer Renewal
12th Oct 20219:00 amRNSNotice of Results
24th Aug 20217:00 amRNSPre-Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.